Ylenia Perone

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

Darren K. Patten, Giacomo Corleone, Balázs Győrffy et al. · Nature Medicine · 2018 · 139 citations · Full text

Medicine, Genetics, Oncology +11

Effect of Cabergoline on Metabolism in Prolactinomas

Renata S. Auriemma, Luciana Granieri, Mariano Galdiero et al. · Neuroendocrinology · 2013 · 117 citations

Medicine, Endocrinology, Pharmacology +15

Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation

Renata S. Auriemma, Ylenia Perone, Antonella Di Sarno et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 113 citations

Medicine, Endocrinology, Pharmacotherapy +16

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

Luca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta et al. · Nature Genetics · 2017 · 90 citations

Medicine, Oncology, Pharmacology +17

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri et al. · Cancers · 2021 · 82 citations · Full text

Medicine, Immunology, Oncology +17